|
|
|
Volumn 28, Issue 2, 2000, Pages 127-136
|
|
Secondary cytoreduction in the treatment of ovarian cancer;Cytoreductions secondaires dans le traitement des cancers de l'ovaire
a
|
|
Author keywords
Intraperitoneal immunochemotherapy; Recurrent ovarian cancer; Secondary cytoreductive surgery
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIOLOGICAL RESPONSE MODIFIER;
BLEOMYCIN;
CISPLATIN;
CYTARABINE;
DOXORUBICIN;
FLUOROURACIL;
IFOSFAMIDE;
SODIUM THIOSULFATE;
THIOTEPA;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER RECURRENCE;
CANCER SURGERY;
CANCER SURVIVAL;
CANCER THERAPY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
OVARY CANCER;
REOPERATION;
SURVIVAL TIME;
TREATMENT INDICATION;
ADJUVANT CHEMOTHERAPY;
CANCER STAGING;
CARCINOMA;
FOLLOW UP;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
OVARY TUMOR;
PATHOLOGY;
SURVIVAL;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
REOPERATION;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 0034050247
PISSN: 12979589
EISSN: 17696682
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (27)
|
